Brosnan, J
[7] [9] [3] Reproductive warnings have also been issued for men using the drug
In another phase 1b human study conducted in the USA (ClinicalTrials.gov, NCT04143802), LY3437943 was compared with a placebo and 1.5 mg dulaglutide in patients with T2DM, demonstrating a dose-dependent body weight reduction in the LY3437943 group (68)
Related PDB-101 Resources Browse Drug Action Browse Cancer Browse Molecules for a Sustainable Future Browse Toxins and Poisons References 3zmk, 3zml: JM Riveron, C Yunta, SS Ibrahim, R Djouaka, H Irving, BD Menze, HM Ismail, J Hemingway, H Ranson, A Albert & CS Wondji (2014) A single mutation in the GSTe2 gene allows tracking of metabolically based insecticide resistance in a major malaria vector
1 2 3 "Glutathione Metabolism and its Implications for Health"